A study of two drugs Amritvalli-Ghrit and Aragvadhadi-ghrit after Therapeutic Emesis in Ek-Kustha (Psoriasis)

A comparative clinical study on efficacy of Vamanottara Amá¹?tavallÄ«-Ghá¹?ta and Ä?ragvadhÄ?di-Ghá¹?ta pÄ?na in Ekakuá¹£á¹ha(Psoriasis) in the purview OF â??Snehasya PÄ?namiá¹£á¹aá¹? Å?uddhe Koá¹£á¹heâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052220

Enrollment

Registered

2023-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for trial. 2. Clinically diagnosed and confirmed cases of Psoriasis

Exclusion criteria

Exclusion criteria: 1. Patients with age below 18 and above 60 yrs. 2. Pregnant women and lactating mothers. 3. Patients suffering from serious systemic disorders like Diabetes Mellitus, Cardiac and Renal Disorders, Malignant disease, Major liver disorders etc. 4. Patients having complication of Psoriasis like Psoriatic Arthropathy, erythrodermic psoriasis etc. 5. Patients Contraindicated for vamana karma as per classical Ä?yurveda texts.

Design outcomes

Primary

Measure	Time frame
To see the changes in the PASI Score and the other Subjective parameters grading score.Timepoint: 2 weeks, 4 weeks and 8 weeks	—

Secondary

Measure	Time frame
Changes in the objective parameters of disease. Timepoint: 2 weeks, 4 weeks and 8 weeks	—

Countries

India

Contacts

Public Contactdr nisha gupta

NATIONAL INSTITUTE OF AYURVEDA

hanib921@gmail.com8239210249

Outcome results